biomarkers to guide active surveillance
Published 1 year ago • 272 plays • Length 6:05Download video MP4
Download video MP3
Similar videos
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
6:20
characteristics of mri lesions allowing active surveillance and how to monitor
-
23:14
asco gu21 highlights on imaging and biomarkers
-
11:17
liquid biomarkers in oncology
-
6:51
urine biomarkers for diagnosis and follow-up/recurrence
-
9:44
new eau 2022 guidelines: urinary biomarkers for the surveillance of nmibc
-
12:46
what role do markers play in establishing active surveillance or definitive care?
-
49:07
active surveillance with dr. laurence klotz - zero prostate cancer summit 2022
-
8:53
prognostic biomarkers to guide treatment of mcrpc
-
20:50
active surveillance 2021 - from bench to bedside
-
12:13
biomarkers’ integration with clinical parameters, imaging, and prognostic instruments
-
1:37
recent advances in mhspc: 177lu-psma-617, propel and biomarker-directed strategies
-
54:39
urowebinar: mri and active surveillance in prostate cancer
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
29:23
how should we monitor patients during surveillance?
-
5:00
screening, active surveillance and prostate cancer biomarkers
-
28:33
active surveillance results and implications of prospective studies
-
50:38
the impact of a genomic assay on urologist treatment preference in active surveillance-eligible men
-
11:03
biomarkers for prostate cancer: whom to treat